KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $492,652 | -9.7% | 4,247 | -8.6% | 0.70% | +13.0% |
Q2 2023 | $545,558 | -6.2% | 4,647 | -36.0% | 0.62% | -9.3% |
Q1 2023 | $581,716 | +5.9% | 7,266 | +4.7% | 0.68% | +1.3% |
Q4 2022 | $549,549 | +109.8% | 6,937 | +84.4% | 0.67% | +134.7% |
Q3 2022 | $262,000 | -15.5% | 3,762 | -20.4% | 0.28% | -8.9% |
Q2 2022 | $310,000 | -86.4% | 4,727 | -86.2% | 0.31% | -77.4% |
Q1 2022 | $2,278,000 | -36.0% | 34,242 | -32.8% | 1.39% | -12.8% |
Q4 2021 | $3,562,000 | +172.3% | 50,922 | +103.3% | 1.59% | +234.7% |
Q3 2021 | $1,308,000 | +13.8% | 25,044 | +48.2% | 0.48% | +25.3% |
Q2 2021 | $1,149,000 | -11.8% | 16,900 | 0.0% | 0.38% | -24.8% |
Q1 2021 | $1,302,000 | +119.2% | 16,900 | +70.7% | 0.50% | +12.2% |
Q4 2020 | $594,000 | – | 9,900 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 895,000 | $31,079,000 | 9.72% |
Knoll Capital Management, LLC | 120,212 | $4,174,000 | 3.82% |
S Squared Technology, LLC | 67,533 | $2,345,000 | 2.07% |
Redmile Group, LLC | 1,078,300 | $37,444,000 | 1.25% |
EAM Investors, LLC | 87,914 | $3,053,000 | 0.81% |
Consonance Capital Management LP | 224,090 | $7,782,000 | 0.77% |
EAM Global Investors LLC | 41,329 | $1,435,000 | 0.70% |
SPHERA FUNDS MANAGEMENT LTD. | 117,625 | $4,085,000 | 0.63% |
GARNET EQUITY CAPITAL HOLDINGS, INC. | 28,000 | $972,000 | 0.62% |
Atika Capital Management LLC | 58,319 | $2,026,000 | 0.43% |